Q4 2025 Holdings
Filed 2026-02-17 | 38 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $391.1M | 3,007,164 | 24.3% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $205.3M | 2,577,333 | 12.8% |
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $144.0M | 5,957,165 | 8.9% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $113.6M | 88,783,856 | 7.1% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $110.0M | 13,003,574 | 6.8% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $81.7M | 1,175,000 | 5.1% |
| Illumina Inc(ILMN) | COM | 452327109 | $78.7M | 600,000 | 4.9% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $72.1M | 1,000,000 | 4.5% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $44.4M | 1,600,000 | 2.8% |
| Guardant Health Inc(GH) | COM | 40131M109 | $38.8M | 380,000 | 2.4% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $31.4M | 758,857 | 2.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $30.4M | 1,840,000 | 1.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $29.8M | 75,000 | 1.9% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $26.7M | 1,295,361 | 1.7% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $22.8M | 1,400,000 | 1.4% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $18.6M | 1,600,000 | 1.2% |
| Tempus AI Inc(TEM) | CL A | 88023B103 | $17.4M | 294,127 | 1.1% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $16.5M | 50,000 | 1.0% |
| Septerna Inc(SEPN) | COM | 81734D104 | $15.4M | 553,268 | 1.0% |
| Hims & Hers Health Inc(HIMS) | COM CL A | 433000106 | $12.5M | 385,000 | 0.8% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $11.6M | 276,308 | 0.7% |
| Dexcom Inc(DXCM) | COM | 252131107 | $11.6M | 175,000 | 0.7% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $11.5M | 260,000 | 0.7% |
| The Cigna Group(CI) | COM | 125523100 | $11.0M | 40,000 | 0.7% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $11.0M | 3,167,175 | 0.7% |
| Incyte Corp(INCY) | COM | 45337C102 | $9.9M | 100,000 | 0.6% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $8.7M | 50,000 | 0.5% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $8.3M | 1,500,000 | 0.5% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $7.9M | 4,223,767 | 0.5% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $4.7M | 215,000 | 0.3% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $3.5M | 282,312 | 0.2% |
| Absci Corporation(ABSI) | COM | 00091E109 | $3.4M | 973,260 | 0.2% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $1.7M | 148,333 | 0.1% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $1.3M | 86,014 | 0.1% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $1.2M | 1,228,190 | 0.1% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $676.2K | 165,323 | 0.0% |
| Ginkgo Bioworks Holdings Inc(DNA) | CL A NEW | 37611X209 | $303.3K | 36,493 | 0.0% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $257.5K | 361,969 | 0.0% |